Trials / Not Yet Recruiting
Not Yet RecruitingNCT07353450
A Study of Cizutamig for Patients With Ulcerative Colitis
An Open-Label, Single Center Study Evaluating the Safety, Tolerability, and Immunogenicity of Cizutamig for Patients With Moderate to Severe Ulcerative Colitis
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A Study of Cizutamig for Patients with Ulcerative Colitis
Detailed description
An Open-Label, Single Center Study Evaluating the Safety, Tolerability, and Immunogenicity of Cizutamig for Patients with Moderate to Severe Ulcerative Colitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | cizutamig | Cizutamig will be dosed according to the protocol |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2026-01-20
- Last updated
- 2026-01-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07353450. Inclusion in this directory is not an endorsement.